Grupo Mabel

Grupo Mabel company information, Employees & Contact Information

Explore related pages

Related company profiles:

.

Company Details

Employees
399
Founded
-
Address
Br 153, Km 13 Jardim Paraíso, Aparecida De Goiânia,goiás 74984431,brazil
Phone
55 62 4006 6213
Industry
Food And Beverage Services
NAICS
Food Services and Drinking Places
Special Food Services
Food Service Contractors
HQ
Aparecida de Goiânia, Goiás
Looking for a particular Grupo Mabel employee's phone or email?

Grupo Mabel Questions

News

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults - PR Newswire

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults PR Newswire

Get Summer-Ready: BLA’s Top 5 Dealer Essentials for the Boating Season - Marine Business News

Get Summer-Ready: BLA’s Top 5 Dealer Essentials for the Boating Season Marine Business News

Tatis sues company to void future earnings deal - ESPN

Tatis sues company to void future earnings deal ESPN

Who are the BLA – the group behind Pakistan’s deadly train hijack? - Al Jazeera

Who are the BLA – the group behind Pakistan’s deadly train hijack? Al Jazeera

FDA Grants Priority Review for Biologics License Application (BLA) and EMA Accepts Marketing Authorisation Application (MAA) for Apitegromab as a Treatment for Spinal Muscular Atrophy - Business Wire

FDA Grants Priority Review for Biologics License Application (BLA) and EMA Accepts Marketing Authorisation Application (MAA) for Apitegromab as a Treatment for Spinal Muscular Atrophy Business Wire

FDA Assigns BTD and Receives BLA for RP1 Combo in Advanced Melanoma - CancerNetwork

FDA Assigns BTD and Receives BLA for RP1 Combo in Advanced Melanoma CancerNetwork

FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025 - PR Newswire

FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025 PR Newswire

Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease - Business Wire

Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease Business Wire

BLA takes popular Trade Show to Perth - Marine Business News

BLA takes popular Trade Show to Perth Marine Business News

SMOKERS’ CORNER: THE BLA RECKONING - Dawn

SMOKERS’ CORNER: THE BLA RECKONING Dawn

BLA Submitted for Muscle-Promoting Therapy Apitegromab as New Treatment for Spinal Muscular Atrophy - NeurologyLive

BLA Submitted for Muscle-Promoting Therapy Apitegromab as New Treatment for Spinal Muscular Atrophy NeurologyLive

Sarepta Therapeutics Announces That U.S. FDA has Accepted for Filing and Granted Priority Review for the Biologics License Application for SRP-9001, Sarepta’s Gene Therapy for the Treatment of Ambulant Individuals with Duchenne Muscular Dystrophy - Sarepta Therapeutics

Sarepta Therapeutics Announces That U.S. FDA has Accepted for Filing and Granted Priority Review for the Biologics License Application for SRP-9001, Sarepta’s Gene Therapy for the Treatment of Ambulant Individuals with Duchenne Muscular Dystrophy Sarepta Therapeutics

FDA issues complete response letter to Outlook Therapeutics for resubmitted BLA for ONS-5010 - Ophthalmology Times

FDA issues complete response letter to Outlook Therapeutics for resubmitted BLA for ONS-5010 Ophthalmology Times

Novo Nordisk submits Biologics License Application (BLA) to FDA for Mim8; an investigational, prophylaxis treatment for people living with hemophilia A with or without inhibitors - Yahoo Finance

Novo Nordisk submits Biologics License Application (BLA) to FDA for Mim8; an investigational, prophylaxis treatment for people living with hemophilia A with or without inhibitors Yahoo Finance

Valneva Completes BLA Submission to U.S. FDA for its Single-Shot Chikungunya Vaccine Candidate - valneva.com

Valneva Completes BLA Submission to U.S. FDA for its Single-Shot Chikungunya Vaccine Candidate valneva.com

FDA Accepts Remestemcel-L BLA Resubmission for Acute GVHD - Targeted Oncology

FDA Accepts Remestemcel-L BLA Resubmission for Acute GVHD Targeted Oncology

Capricor Formally Submits BLA for Deramiocel in Duchenne Muscular Dystrophy Cardiomyopathy - NeurologyLive

Capricor Formally Submits BLA for Deramiocel in Duchenne Muscular Dystrophy Cardiomyopathy NeurologyLive

Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA) - Business Wire

Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA) Business Wire

Nanoscope Therapeutics initiates rolling submission of BLA to FDA for MCO-010 - Ophthalmology Times

Nanoscope Therapeutics initiates rolling submission of BLA to FDA for MCO-010 Ophthalmology Times

Pierre Fabre Pharmaceuticals Inc. Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Tabelecleucel for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) - PR Newswire

Pierre Fabre Pharmaceuticals Inc. Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Tabelecleucel for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) PR Newswire

BLA brainwashes, incites people to terrorism: ex-member - Dawn

BLA brainwashes, incites people to terrorism: ex-member Dawn

BLA claims responsibility for killing Mir Attaur Rehman Mengal - Dawn

BLA claims responsibility for killing Mir Attaur Rehman Mengal Dawn

FDA Issues Complete Response Letter to Linvoseltamab BLA in R/R Multiple Myeloma - OncLive

FDA Issues Complete Response Letter to Linvoseltamab BLA in R/R Multiple Myeloma OncLive

Timeline: Attacks claimed by BLA over the last one year - Dawn

Timeline: Attacks claimed by BLA over the last one year Dawn

Gq neuromodulation of BLA parvalbumin interneurons induces burst firing and mediates fear-associated network and behavioral state transition in mice - Nature

Gq neuromodulation of BLA parvalbumin interneurons induces burst firing and mediates fear-associated network and behavioral state transition in mice Nature

BLA among main perpetrators of terror in 2024 - Dawn

BLA among main perpetrators of terror in 2024 Dawn

Ultragenyx initiates rolling BLA submission for GSDIa gene therapy - Investing.com

Ultragenyx initiates rolling BLA submission for GSDIa gene therapy Investing.com

Indians' Mejia sues over financial deal - MLB.com

Indians' Mejia sues over financial deal MLB.com

Eisai, Biogen Launch Rolling BLA for Subcutaneous Alzheimer’s Therapy Leqembi - BioSpace

Eisai, Biogen Launch Rolling BLA for Subcutaneous Alzheimer’s Therapy Leqembi BioSpace

Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II) - GlobeNewswire

Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II) GlobeNewswire

Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome - GlobeNewswire

Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome GlobeNewswire

Neurotech Pharmaceuticals, Inc. Receives Priority Review of Biologics License Application (BLA) for NT-501 (revakinagene taroretcel) as a Treatment for Macular Telangiectasia Type 2 (MacTel) - Business Wire

Neurotech Pharmaceuticals, Inc. Receives Priority Review of Biologics License Application (BLA) for NT-501 (revakinagene taroretcel) as a Treatment for Macular Telangiectasia Type 2 (MacTel) Business Wire

Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer - Business Wire

Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer Business Wire

Russia's Killer Drone in Ukraine Raises Fears About AI in Warfare - WIRED

Russia's Killer Drone in Ukraine Raises Fears About AI in Warfare WIRED

Make Important Email Standout in Outlook with Color Coding - Techlicious

Make Important Email Standout in Outlook with Color Coding Techlicious

BLA exploiting kids for arms smuggling, attacks: CTD - Dawn

BLA exploiting kids for arms smuggling, attacks: CTD Dawn

‘Blah, blah, blah’: Greta Thunberg lambasts leaders over climate crisis - The Guardian

‘Blah, blah, blah’: Greta Thunberg lambasts leaders over climate crisis The Guardian

A Pakistani separatist group claims bombing that killed 2 Chinese near Karachi airport - AP News

A Pakistani separatist group claims bombing that killed 2 Chinese near Karachi airport AP News

Pakistan: Woman suicide bomber change in Baloch rebels’ strategy? - Al Jazeera

Pakistan: Woman suicide bomber change in Baloch rebels’ strategy? Al Jazeera

Industry Ink: ASCAP Foundation, The Recording Academy, KCA, BLA - MusicRow.com

Industry Ink: ASCAP Foundation, The Recording Academy, KCA, BLA MusicRow.com

Pakistan: At least 22 killed after having IDs checked in Balochistan - BBC

Pakistan: At least 22 killed after having IDs checked in Balochistan BBC

Rosenthal: Company that offers minor leaguers up-front payments drawing scrutiny within baseball - The New York Times

Rosenthal: Company that offers minor leaguers up-front payments drawing scrutiny within baseball The New York Times

Industry Ink: BLA, Catch This Music, Matt Rizor Fundraiser - MusicRow.com

Industry Ink: BLA, Catch This Music, Matt Rizor Fundraiser MusicRow.com

BLA-TTP collaboration in Balochistan: alliance or anomaly? - Dawn

BLA-TTP collaboration in Balochistan: alliance or anomaly? Dawn

Pakistan welcomes US designation of BLA, Majeed Brigade as foreign terrorist organisations - Dawn

Pakistan welcomes US designation of BLA, Majeed Brigade as foreign terrorist organisations Dawn

BLA Adds Brian Waymire As Agent - MusicRow.com

BLA Adds Brian Waymire As Agent MusicRow.com

BLA extorting money from mine owners, claims Balochistan minister - Dawn

BLA extorting money from mine owners, claims Balochistan minister Dawn

BLA commander killed in Kech operation: ISPR - Dawn

BLA commander killed in Kech operation: ISPR Dawn

BLA’s system failure ongoing - nationnews.com

BLA’s system failure ongoing nationnews.com

A radical shift in insurgency - Dawn

A radical shift in insurgency Dawn

‘BLA man’ held in Karachi’s Lyari raid - Dawn

‘BLA man’ held in Karachi’s Lyari raid Dawn

Why 'Blak' not Black?: Artist Destiny Deacon and the origins of this word - SBS Australia

Why 'Blak' not Black?: Artist Destiny Deacon and the origins of this word SBS Australia

Explained: The Baloch Liberation Army - The Hindu

Explained: The Baloch Liberation Army The Hindu

Two BLA leaders, 23 companions surrender in Quetta - Dawn

Two BLA leaders, 23 companions surrender in Quetta Dawn

YAK FISHING: Getting Set Up - Fishing World Australia

YAK FISHING: Getting Set Up Fishing World Australia

Bla Kondixin back on stage - MaltaToday

Bla Kondixin back on stage MaltaToday

Top Grupo Mabel Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant